Why CSL, Incitec Pivot, Lake Resources and St Barbara are pushing higher

Image source: Getty Images

In the afternoon discussions, the S&P/ASX 200 Index (ASX:XJO) runs out of steam and begins to slide lower. As of this writing, the benchmark is down 0.4% to 7,012.1 points.

Four ASX shares that do not retain them are listed below. Here’s why they grow taller:

CSL stock price rose 3% to $256.98. Investors bought the shares of this biotherapy giant following reports that the TGA has approved a super flu vaccine by its company Seqirus for children as young as two years old. The Flucelvax Quad vaccine was the first cell-based seasonal influenza vaccine offered in Australia when it was first approved in 2021. Prior to TGA approval, CSL had distributed 100 million doses worldwide .

Incitec Pivot stock price is up nearly 2% at $3.53. This morning, shares of the agricultural chemicals company were updated by Credit Suisse analysts. According to the rating, the broker has put an outperformance rating and a price target of $3.85 on its shares. He thinks Incitec Pivot will benefit from higher fertilizer prices.

Lake Resources’ share price is up 2% at $1.01. This seems to have been prompted by the news that the lithium explorer has raised $39 million thanks to a market increase. Pursuant to its agreement with Acuity Capital, it raised the funds by issuing 40 million shares at 97.5 cents per new share.

the St Barbara Ltd (ASX:SBM) stock price is up 8% at $1.53. Investors bid the gold miner’s shares higher today amid speculation it could be a takeover target. Nearby peers Northern Star Resources Ltd. (ASX:NST) and Ramélius Resources Limited (ASX:RMS) may be interested in the downed gold miner’s Gwalia underground mine and processing plant.